Causeway Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ovintiv
OVV
|
+$208M |
| 2 |
Sabre
SABR
|
+$155M |
| 3 |
Halliburton
HAL
|
+$144M |
| 4 |
Manulife Financial
MFC
|
+$104M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$94.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PVH
PVH
|
+$115M |
| 2 |
Infosys
INFY
|
+$16.9M |
| 3 |
TTM
Tata Motors Limited
TTM
|
+$16.8M |
| 4 |
TSMC
TSM
|
+$16.4M |
| 5 |
NetEase
NTES
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.4% |
| 2 | Energy | 16.94% |
| 3 | Consumer Discretionary | 13.99% |
| 4 | Financials | 13.88% |
| 5 | Industrials | 11.52% |
Similar funds
Causeway Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Causeway Capital Management held 87 positions worth $8.07B, up 9.3% from $7.38B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Causeway Capital Management deployed $1.16B of net new capital in Q2 2017, opening 6 new positions and adding to 44 existing holdings. Its largest new stake was Sabre: 6,803,547 shares worth $148M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Infosys, an estimated $16.9M trimmed.
- Causeway Capital Management's largest Q2 2017 buy was Sabre: 6,803,547 shares worth $148M.
- Causeway Capital Management added most to Ovintiv in Q2 2017, an estimated $208M increase.
- Causeway Capital Management's biggest Q2 2017 reduction was Infosys, cutting an estimated $16.9M.
- Causeway Capital Management fully exited PVH in Q2 2017, selling an estimated $115M.
- Causeway Capital Management's ten largest holdings make up 55% of its $8.07B portfolio in Q2 2017.
- Causeway Capital Management opened 6 new positions and closed 4 in Q2 2017.
- Causeway Capital Management's portfolio value rose 9.3% quarter-over-quarter to $8.07B.
Based on Causeway Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.